Results 191 to 200 of about 13,605,822 (324)

Engineering Ultrasound Contrast Agents for Targeted Therapeutics: A Theranostic Approach to Drug Delivery, Gene Therapy, and Immunomodulation

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
Ultrasound contrast agents, including microbubbles and nanobubbles, transform imaging and targeted therapy through precise engineering of size, shell composition, and surface properties. This review explores how these innovations enable tissue‐specific delivery, enhance therapeutic efficacy, and extend applications from vascular imaging to tumor ...
Ashkan Seza   +2 more
wiley   +1 more source

Dual Modality Semiconducting Polymer Nanoparticles for Use in Optical and Magnetic Resonance Imaging

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
Well‐defined dual‐modality semiconducting polymer nanoparticles composed of red‐emitting conjugated polymers functionalized with novel gadolinium‐based contrast agents have been prepared. The assemblies show a greatly enhanced relaxivity performance compared to the clinical standard, Dotarem, while offering ultrabright fluorescence, ideal for optical ...
Faysal A. Farah   +5 more
wiley   +1 more source

Time‐Resolved Fluorescence and Diffuse Reflectance (TRF‐DR) Spectroscopy for Heterogeneous Breast Tissue Classification and Tumor Margin Assessment

open access: yesJournal of Biophotonics, Volume 19, Issue 2, February 2026.
This study demonstrates our time‐resolved fluorescence and diffuse reflectance spectroscopy system can classify breast tumor in heterogeneous tissue. It achieved sensitivity and specificity comparable to other techniques and highlights the effect of heterogeneous measurements on performance.
Jigar Lad   +6 more
wiley   +1 more source

Supplementary video from Longitudinal Photoacoustic Imaging of the Pharmacodynamic Effect of Vascular Targeted Therapy on Tumors

open access: gold, 2023
Sean Peter Johnson   +4 more
openalex   +1 more source

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy